United States Subcutaneous Biologics Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Definition and Specifications of Subcutaneous Biologics

1.1.1 Definition of Subcutaneous Biologics

1.1.2 Specifications of Subcutaneous Biologics

1.2 Classification of Subcutaneous Biologics

1.2.1 Insulin Pumps with Infusion Sets

1.2.2 Insulin Patch Pumps

1.2.3 Transdermal Patch

1.2.4 Bolus Injectors

1.3 Applications of Subcutaneous Biologics

1.4 Industry Chain Structure of Subcutaneous Biologics

1.5 Industry Overview of Subcutaneous Biologics

1.6 Industry Policy Analysis of Subcutaneous Biologics

1.7 Industry News Analysis of Subcutaneous Biologics

2 Manufacturing Cost Structure Analysis of Subcutaneous Biologics

2.1 Bill of Materials (BOM) of Subcutaneous Biologics

2.2 BOM Price Analysis of Subcutaneous Biologics

2.3 Labor Cost Analysis of Subcutaneous Biologics

2.4 Depreciation Cost Analysis of Subcutaneous Biologics

2.5 Manufacturing Cost Structure Analysis of Subcutaneous Biologics

2.6 Manufacturing Process Analysis of Subcutaneous Biologics

2.7 United States Price, Cost and Gross of Subcutaneous Biologics 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015

4 Production Analysis of Subcutaneous Biologics by Regions, Type, and Applications

4.1 United States Production of Subcutaneous Biologics by Regions 2011-2016

4.2 United States Production of Subcutaneous Biologics by Type 2011-2016

4.3 United States Sales of Subcutaneous Biologics by Applications 2011-2016

4.4 Price Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Subcutaneous Biologics 2011-2016

5 Consumption Volume and Consumption Value Analysis of Subcutaneous Biologics by Regions

5.1 United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016

5.2 United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016

5.3 United States Consumption Price Analysis of Subcutaneous Biologics by Regions 2011-2016

6 Analysis of Subcutaneous Biologics Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Subcutaneous Biologics 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Subcutaneous Biologics 2014-2015

6.3 Sales Overview of Subcutaneous Biologics 2011-2016

6.4 Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016

6.5 Import, Export and Consumption of Subcutaneous Biologics 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2011-2016

7 Analysis of Subcutaneous Biologics Industry Key Manufacturers

7.1 Abbott Laboratories

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Activa

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Adamis Pharmaceuticals Corporation

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 ADOCIA

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Advantage Health Services

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 Aguettant

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Ajinomoto Althea Inc.

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 Alnylam Pharmaceuticals

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Amgen

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 Antares Pharma

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

7.11 Aptar Pharm

7.11.1 Company Profile

7.11.2 Product Picture and Specifications

7.11.2.1 Type I

7.11.2.2 Type II

7.11.2.3 Type III

7.11.3 Capacity, Production, Price, Cost, Gross and Revenue

7.11.4 Contact Information

7.12 Aradigm Corporation

7.12.1 Company Profile

7.12.2 Product Picture and Specifications

7.12.2.1 Type I

7.12.2.2 Type II

7.12.2.3 Type III

7.12.3 Capacity, Production, Price, Cost, Gross and Revenue

7.12.4 Contact Information

7.13 Arte Corporation

7.13.1 Company Profile

7.13.2 Product Picture and Specifications

7.13.2.1 Type I

7.13.2.2 Type II

7.13.2.3 Type III

7.13.3 Capacity, Production, Price, Cost, Gross and Revenue

7.13.4 Contact Information

7.14 Ascendis Pharma

7.14.1 Company Profile

7.14.2 Product Picture and Specifications

7.14.2.1 Type I

7.14.2.2 Type II

7.14.2.3 Type III

7.14.3 Capacity, Production, Price, Cost, Gross and Revenue

7.14.4 Contact Information

7.15 AstraZeneca

7.15.1 Company Profile

7.15.2 Product Picture and Specifications

7.15.2.1 Type I

7.15.2.2 Type II

7.15.2.3 Type III

7.15.3 Capacity, Production, Price, Cost, Gross and Revenue

7.15.4 Contact Information

7.16 Bang and Olufsen

7.16.1 Company Profile

7.16.2 Product Picture and Specifications

7.16.2.1 Type I

7.16.2.2 Type II

7.16.2.3 Type III

7.16.3 Capacity, Production, Price, Cost, Gross and Revenue

7.16.4 Contact Information

7.17 Battelle

7.17.1 Company Profile

7.17.2 Product Picture and Specifications

7.17.2.1 Type I

7.17.2.2 Type II

7.17.2.3 Type III

7.17.3 Capacity, Production, Price, Cost, Gross and Revenue

7.17.4 Contact Information

7.18 Baxter

7.18.1 Company Profile

7.18.2 Product Picture and Specifications

7.18.2.1 Type I

7.18.2.2 Type II

7.18.2.3 Type III

7.18.3 Capacity, Production, Price, Cost, Gross and Revenue

7.18.4 Contact Information

7.19 Bayer

7.19.1 Company Profile

7.19.2 Product Picture and Specifications

7.19.2.1 Type I

7.19.2.2 Type II

7.19.2.3 Type III

7.19.3 Capacity, Production, Price, Cost, Gross and Revenue

7.19.4 Contact Information

7.20 Becton Dickinson

7.20.1 Company Profile

7.20.2 Product Picture and Specifications

7.20.2.1 Type I

7.20.2.2 Type II

7.20.2.3 Type III

7.20.3 Capacity, Production, Price, Cost, Gross and Revenue

7.20.4 Contact Information

7.21 Bespak

7.21.1 Company Profile

7.21.2 Product Picture and Specifications

7.21.2.1 Type I

7.21.2.2 Type II

7.21.2.3 Type III

7.21.3 Capacity, Production, Price, Cost, Gross and Revenue

7.21.4 Contact Information

7.22 Biogen Idec

7.22.1 Company Profile

7.22.2 Product Picture and Specifications

7.22.2.1 Type I

7.22.2.2 Type II

7.22.2.3 Type III

7.22.3 Capacity, Production, Price, Cost, Gross and Revenue

7.22.4 Contact Information

7.23 Bioject Medical Technologies, Inc.

7.23.1 Company Profile

7.23.2 Product Picture and Specifications

7.23.2.1 Type I

7.23.2.2 Type II

7.23.2.3 Type III

7.23.3 Capacity, Production, Price, Cost, Gross and Revenue

7.23.4 Contact Information

7.24 Bristol-Myers Squibb Co

7.24.1 Company Profile

7.24.2 Product Picture and Specifications

7.24.2.1 Type I

7.24.2.2 Type II

7.24.2.3 Type III

7.24.3 Capacity, Production, Price, Cost, Gross and Revenue

7.24.4 Contact Information

7.25 Calibra Medical

7.25.1 Company Profile

7.25.2 Product Picture and Specifications

7.25.2.1 Type I

7.25.2.2 Type II

7.25.2.3 Type III

7.25.3 Capacity, Production, Price, Cost, Gross and Revenue

7.25.4 Contact Information

7.26 CeQur SA

7.26.1 Company Profile

7.26.2 Product Picture and Specifications

7.26.2.1 Type I

7.26.2.2 Type II

7.26.2.3 Type III

7.26.3 Capacity, Production, Price, Cost, Gross and Revenue

7.26.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Subcutaneous Biologics Product Types

8.5 Market Share Analysis of Different Subcutaneous Biologics Price Levels

8.6 Gross Margin Analysis of Different Subcutaneous Biologics Applications

9 Marketing Trader or Distributor Analysis of Subcutaneous Biologics

9.1 Marketing Channels Status of Subcutaneous Biologics

9.2 Traders or Distributors of Subcutaneous Biologics with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Subcutaneous Biologics

9.4 United States Import, Export and Trade Analysis of Subcutaneous Biologics

10 Development Trend of Subcutaneous Biologics Industry 2016-2021

10.1 Capacity and Production Overview of Subcutaneous Biologics 2016-2021

10.2 Production Market Share by Product Types of Subcutaneous Biologics 2016-2021

10.3 Sales and Sales Revenue Overview of Subcutaneous Biologics 2016-2021

10.4 United States Sales of Subcutaneous Biologics by Applications 2016-2021

10.5 Import, Export and Consumption of Subcutaneous Biologics 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2016-2021

11 Industry Chain Suppliers of Subcutaneous Biologics with Contact Information

11.1 Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information

11.2 Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information

11.3 Major Players of Subcutaneous Biologics with Contact Information

11.4 Key Consumers of Subcutaneous Biologics with Contact Information

11.5 Supply Chain Relationship Analysis of Subcutaneous Biologics

12 New Project Investment Feasibility Analysis of Subcutaneous Biologics

12.1 New Project SWOT Analysis of Subcutaneous Biologics

12.2 New Project Investment Feasibility Analysis of Subcutaneous Biologics

13 Conclusion of the United States Subcutaneous Biologics Industry 2016 Market Research Report

Figure Picture of Subcutaneous Biologics

Table Product Specifications of Subcutaneous Biologics

Table Classification of Subcutaneous Biologics

Figure United States Sales Market Share of Subcutaneous Biologics by Product Types in 2015

Table Applications of Subcutaneous Biologics

Figure United States Sales Market Share of Subcutaneous Biologics by Applications in 2015

Figure Industry Chain Structure of Subcutaneous Biologics

Table United States Industry Overview of Subcutaneous Biologics

Table Industry Policy of Subcutaneous Biologics

Table Industry News List of Subcutaneous Biologics

Table Bill of Materials (BOM) of Subcutaneous Biologics

Table Bill of Materials (BOM) Price of Subcutaneous Biologics

Table Labor Cost of Subcutaneous Biologics

Table Depreciation Cost of Subcutaneous Biologics

Table Manufacturing Cost Structure Analysis of Subcutaneous Biologics in 2015

Figure Manufacturing Process Analysis of Subcutaneous Biologics

Table United States Price Analysis of Subcutaneous Biologics 2011-2016 (USD/Unit)

Table United States Cost Analysis of Subcutaneous Biologics 2011-2016 (USD/Unit)

Table United States Gross Analysis of Subcutaneous Biologics 2011-2016

Table Capacity (Unit) and Commercial Production Date of United States Subcutaneous Biologics Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015

Table R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Subcutaneous Biologics Key Manufacturers in 2015

Table United States Production of Subcutaneous Biologics by Regions 2011-2016 (Unit)

Table United States Production Market Share of Subcutaneous Biologics by Regions 2011-2016

Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2014

Figure United States Production Market Share of Subcutaneous Biologics by Regions in 2015

Table United States Production of Subcutaneous Biologics by Types in 2011-2016 (Unit)

Table United States Production Market Share of Subcutaneous Biologics by Type in 2011-2016

Figure United States Production Market Share of Subcutaneous Biologics by Type in 2014

Figure United States Production Market Share of Subcutaneous Biologics by Type in 2015

Table United States Sales of Subcutaneous Biologics by Applications 2011-2016 (Unit)

Table United States Production Market Share of Subcutaneous Biologics by Applications 2011-2016

Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2014

Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2015

Table Price Comparison of United States Subcutaneous Biologics Key Manufacturers in 2015 (USD/Unit)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Subcutaneous Biologics 2011-2016

Table United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016 (Unit)

Table United States Consumption Volume Market Share of Subcutaneous Biologics by Regions 2011-2016

Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2014

Figure United States Consumption Volume Market Share of Subcutaneous Biologics by Regions in 2015

Table United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Subcutaneous Biologics by Regions 2011-2016

Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2014

Figure United States Consumption Value Market Share of Subcutaneous Biologics by Regions in 2015

Table Consumption Price of Subcutaneous Biologics by Regions 2011-2016 (USD/Unit)

Table United States and Major Manufacturers Capacity of Subcutaneous Biologics 2011-2016 (Unit)

Table United States Capacity Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Subcutaneous Biologics 2011-2016 (Unit)

Table United States Production Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Subcutaneous Biologics 2011-2016 (Unit)

Table United States Sales Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Subcutaneous Biologics 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Subcutaneous Biologics Manufacturers 2011-2016

Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016

Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Subcutaneous Biologics 2011-2016

Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2014

Figure United States Production Market Share of Major Subcutaneous Biologics Manufacturers in 2015

Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2014

Figure United States Sales Market Share of Major Subcutaneous Biologics Manufacturers in 2015

Figure United States Sales (Unit) and Growth Rate of Subcutaneous Biologics 2011-2016

Table United States Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016 (Unit)

Table United States Import, Export and Consumption of Subcutaneous Biologics 2011-2016 (Unit)

Table Price of United States Subcutaneous Biologics Major Manufacturers 2011-2016 (USD/Unit)

Table Gross Margin of United States Subcutaneous Biologics Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Subcutaneous Biologics 2011-2016 (M USD)

Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2011-2016

Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Abbott Laboratories

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Abbott Laboratories 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Abbott Laboratories 2011-2016

Table Abbott Laboratories Subcutaneous Biologics SWOT Analysis

Table Activa Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Activa

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Activa 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Activa 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Activa 2011-2016

Table Activa Subcutaneous Biologics SWOT Analysis

Table Adamis Pharmaceuticals Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Adamis Pharmaceuticals Corporation

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Adamis Pharmaceuticals Corporation 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Adamis Pharmaceuticals Corporation 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Adamis Pharmaceuticals Corporation 2011-2016

Table Adamis Pharmaceuticals Corporation Subcutaneous Biologics SWOT Analysis

Table ADOCIA Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of ADOCIA

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ADOCIA 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of ADOCIA 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of ADOCIA 2011-2016

Table ADOCIA Subcutaneous Biologics SWOT Analysis

Table Advantage Health Services Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Advantage Health Services

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Advantage Health Services 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Advantage Health Services 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Advantage Health Services 2011-2016

Table Advantage Health Services Subcutaneous Biologics SWOT Analysis

Table Aguettant Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Aguettant

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aguettant 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aguettant 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aguettant 2011-2016

Table Aguettant Subcutaneous Biologics SWOT Analysis

Table Ajinomoto Althea Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Ajinomoto Althea Inc.

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ajinomoto Althea Inc. 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ajinomoto Althea Inc. 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Ajinomoto Althea Inc. 2011-2016

Table Ajinomoto Althea Inc. Subcutaneous Biologics SWOT Analysis

Table Alnylam Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Alnylam Pharmaceuticals

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Alnylam Pharmaceuticals 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Alnylam Pharmaceuticals 2011-2016

Table Alnylam Pharmaceuticals Subcutaneous Biologics SWOT Analysis

Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Amgen

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Amgen 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Amgen 2011-2016

Table Amgen Subcutaneous Biologics SWOT Analysis

Table Antares Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Antares Pharma

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Antares Pharma 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Antares Pharma 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Antares Pharma 2011-2016

Table Antares Pharma Subcutaneous Biologics SWOT Analysis

Table Aptar Pharm Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Aptar Pharm

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aptar Pharm 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aptar Pharm 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aptar Pharm 2011-2016

Table Aptar Pharm Subcutaneous Biologics SWOT Analysis

Table Aradigm Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Aradigm Corporation

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aradigm Corporation 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Aradigm Corporation 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Aradigm Corporation 2011-2016

Table Aradigm Corporation Subcutaneous Biologics SWOT Analysis

Table Arte Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Arte Corporation

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arte Corporation 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Arte Corporation 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Arte Corporation 2011-2016

Table Arte Corporation Subcutaneous Biologics SWOT Analysis

Table Ascendis Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Ascendis Pharma

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ascendis Pharma 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Ascendis Pharma 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Ascendis Pharma 2011-2016

Table Ascendis Pharma Subcutaneous Biologics SWOT Analysis

Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of AstraZeneca

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of AstraZeneca 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of AstraZeneca 2011-2016

Table AstraZeneca Subcutaneous Biologics SWOT Analysis

Table Bang and Olufsen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Bang and Olufsen

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bang and Olufsen 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bang and Olufsen 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bang and Olufsen 2011-2016

Table Bang and Olufsen Subcutaneous Biologics SWOT Analysis

Table Battelle Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Battelle

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Battelle 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Battelle 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Battelle 2011-2016

Table Battelle Subcutaneous Biologics SWOT Analysis

Table Baxter Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Baxter

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Baxter 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Baxter 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Baxter 2011-2016

Table Baxter Subcutaneous Biologics SWOT Analysis

Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Bayer

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bayer 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bayer 2011-2016

Table Bayer Subcutaneous Biologics SWOT Analysis

Table Becton Dickinson Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Becton Dickinson

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Becton Dickinson 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Becton Dickinson 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Becton Dickinson 2011-2016

Table Becton Dickinson Subcutaneous Biologics SWOT Analysis

Table Bespak Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Bespak

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bespak 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bespak 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bespak 2011-2016

Table Bespak Subcutaneous Biologics SWOT Analysis

Table Biogen Idec Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Biogen Idec

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen Idec 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Biogen Idec 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Biogen Idec 2011-2016

Table Biogen Idec Subcutaneous Biologics SWOT Analysis

Table Bioject Medical Technologies, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Bioject Medical Technologies, Inc.

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bioject Medical Technologies, Inc. 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bioject Medical Technologies, Inc. 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bioject Medical Technologies, Inc. 2011-2016

Table Bioject Medical Technologies, Inc. Subcutaneous Biologics SWOT Analysis

Table Bristol-Myers Squibb Co Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Bristol-Myers Squibb Co

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb Co 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Bristol-Myers Squibb Co 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Bristol-Myers Squibb Co 2011-2016

Table Bristol-Myers Squibb Co Subcutaneous Biologics SWOT Analysis

Table Calibra Medical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of Calibra Medical

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Calibra Medical 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of Calibra Medical 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of Calibra Medical 2011-2016

Table Calibra Medical Subcutaneous Biologics SWOT Analysis

Table CeQur SA Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Subcutaneous Biologics Picture and Specifications of CeQur SA

Table Subcutaneous Biologics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CeQur SA 2011-2016

Figure Subcutaneous Biologics Capacity (Unit), Production (Unit) and Growth Rate of CeQur SA 2011-2016

Figure Subcutaneous Biologics Production (Unit) and United States Market Share of CeQur SA 2011-2016

Table CeQur SA Subcutaneous Biologics SWOT Analysis

Table Subcutaneous Biologics Price by Regions 2011-2016

Table Subcutaneous Biologics Price by Product Types 2011-2016

Table Subcutaneous Biologics Price by Companies 2011-2016

Table Subcutaneous Biologics Gross Margin by Companies 2011-2016

Table Price Comparison of Subcutaneous Biologics by Regions 2011-2016 (USD/Unit)

Table Price of Different Subcutaneous Biologics Product Types (USD/Unit)

Table Market Share of Different Subcutaneous Biologics Price Level

Table Gross Margin of Different Subcutaneous Biologics Applications

Table Marketing Channels Status of Subcutaneous Biologics

Table Traders or Distributors of Subcutaneous Biologics with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Subcutaneous Biologics (USD/Unit) in 2015

Table United States Import, Export, and Trade of Subcutaneous Biologics (Unit)

Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021

Figure United States Capacity Utilization Rate of Subcutaneous Biologics 2016-2021

Table United States Subcutaneous Biologics Production by Type 2016-2021 (Unit)

Table United States Subcutaneous Biologics Production Market Share by Type 2016-2021

Figure United States Production Market Share of Subcutaneous Biologics by Type in 2021

Figure United States Sales (Unit) and Growth Rate of Subcutaneous Biologics 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Subcutaneous Biologics 2016-2021

Figure United States Sales of Subcutaneous Biologics by Applications 2016-2021 (Unit)

Table United States Production Market Share of Subcutaneous Biologics by Applications 2016-2021

Figure United States Production Market Share of Subcutaneous Biologics by Applications in 2021

Table United States Production, Import, Export and Consumption of Subcutaneous Biologics 2016-2021 (Unit)

Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Subcutaneous Biologics 2016-2021

Table Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information

Table Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information

Table Major Players of Subcutaneous Biologics with Contact Information

Table Key Consumers of Subcutaneous Biologics with Contact Information

Table Supply Chain Relationship Analysis of Subcutaneous Biologics

Table New Project SWOT Analysis of Subcutaneous Biologics

Table New Project Investment Feasibility Analysis of Subcutaneous Biologics

Table Part of Interviewees Record List